Pan-cancer characterization of cell-free immune-related miRNA identified as a robust biomarker for cancer diagnosis.

"Declarations Ethics approval and consent to participateThis work was conducted in compliance with the Declaration of Helsinki. Patient data we used were acquired by publicly available datasets that were collected with patients’ informed consent. Competing interestsThe authors declare no competing interests. Competing interests The authors declare no competing interests."

"Funding The National Natural Science Foundation of China (82003160); CAMS Innovation Fund for Medical Sciences (2021-I2M-1-050); The National Natural Science Foundation of China (82203154); Beijing Nova Program of Science and Technology (Z191100001119049); Beijing Natural Science Foundation (No. J20010); Beijing Municipal Science & Technology C mission (Z221100007422011); CAMS Innovation Fund for Medical Sciences (CIFMS) (No. 2021-I2M-C&T-B-018); National High-Level Hospital Clinical Research Funding (2022-PUMCH-A-018, 2022-PUMCH-C-043). The datasets generated and/or analyzed during the current study are available from the corresponding author upon reasonable request. All authors have responsibility for the decision to submit for publication and declare no competing interests."